Glatfelter: Q2 Earnings Insights

  Glatfelter (NYSE:GLT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:50 AM. Here's what investors need to know about the announcement.

 

Glatfelter (NYSE:GLT) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:50 AM.

Here’s what investors need to know about the announcement.

Earnings

Glatfelter beat estimated earnings by 75.0%, reporting an EPS of $-0.04 versus an estimate of $-0.16.

Revenue was up $119.05 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.07 which was followed by a 0.21% drop in the share price the next day.

Here’s a look at Glatfelter’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.07 0.11 0.20 0.14
EPS Actual -0.14 0.04 0.21 0.18
Revenue Estimate 332.75M 353.00M 270.00M 242.00M
Revenue Actual 381.68M 334.46M 279.65M 244.91M

To track all earnings releases for Glatfelter visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Sanofi Announced Pivotal Data Demonstrate Once-weekly Efanesoctocog Alfa Provides Superior Bleed Protection Compared to Prior Factor Prophylaxis

Sanofi and Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) presented for the first time today, in a late-breaking session at the 30th International Society on Thrombosis and Haemostasis (ISTH) Congress, positive results from the XTEND-1 pivotal Phase 3 study evaluating the safety, efficacy and pharmacokinetics of efanesoctocog alfa (BIVV001), an investigational factor VIII replacement therap

SNY